 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
1 September 1997 | Volume 127 Issue 5 | Pages 346-355
Background: Researchers have suggested that the deletional allele of the ACE (angiotensin-converting enzyme) gene insertion-deletion polymorphism is a potent risk factor for myocardial infarction. This association could not be confirmed in the Copenhagen City Heart Study, in which 10 150 persons were studied. The ACE gene polymorphism has also recently been suggested as a potent risk factor for ischemic cerebrovascular disease.
Objective: To investigate the association between ACE gene polymorphism and ischemic cerebrovascular disease.
Design: Two case-referent studies and a cross-sectional study.
Setting: University hospital in Copenhagen, Denmark.
Participants: Case-referent study 1: 35 women and 38 men who developed ischemic cerebrovascular disease before 50 years of age compared with 1454 women and 1737 men from a general population sample. Case-referent study 2: 82 women and 137 men with ischemic cerebrovascular disease and carotid stenosis greater than 40% compared with 4273 women and 3091 men from the general population sample. Cross-sectional study of the general population sample: 67 women and 93 men with ischemic cerebrovascular disease compared with 4077 women and 3156 men without such disease.
Measurements: Genotype; age; body mass index; smoking habits; levels of lipids, lipoproteins, apolipoproteins, and fibrinogen; and diagnosis of hypertension, diabetes mellitus, and ischemic cerebrovascular disease.
Results: Odds ratios for ischemic cerebrovascular disease by ACE genotype classes were not significantly different from 1.0 in women or men in any of the three studies, separately or combined. In a logistic regression analysis that controlled for age and conventional cardiovascular risk factors, odds ratios in either sex still did not significantly differ from 1.0 in any study, separately or combined.
Conclusion: In two case-referent studies, a cross-sectional study, and the three studies combined, no statistically significant difference was found in the development of ischemic cerebrovascular disease between genotype classes of the ACE gene polymorphism in women or men.
Author and Article Information
From the Herlev University Hospital, Herlev, Denmark; and National University Hospital and University of Copenhagen, Copenhagen, Denmark.
ARTICLE
ACE Gene Polymorphism as a Risk Factor for Ischemic Cerebrovascular Disease
Acknowledgments: The authors thank Poul Westermann and Mette Refstrup for technical assistance and Merete Appleyard for advice on the Copenhagen City Heart Study database.
Grant Support: By the Danish Heart Foundation, the Danish Research Academy, Copenhagen County, and Chief Physician Johan Boserup's and Lise Boserup's Fund.
Requests for Reprints: Borge G. Nordestgaard, MD, DMSc, Department of Clinical Biochemistry, Herlev University Hospital, DK-2730 Herlev, Denmark.
Current Author Addresses: Ms. Agerholm-Larsen and Drs. Tybjaerg-Hansen Frikke-Schmidt, and Nordestgaard: Department of Clinical Biochemistry, Herlev University Hospital, DK-2730 Herlev, Denmark.
Related articles in Annals:
This article has been cited by other articles:
|
|
 |
|
  J. P. Casas, A. D. Hingorani, L. E. Bautista, and P. Sharma Meta-analysis of Genetic Studies in Ischemic Stroke: Thirty-two Genes Involving Approximately 18 000 Cases and 58 000 Controls Arch Neurol, November 1, 2004; 61(11): 1652 - 1661. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Gwinn-Hardy and V. Dawson Genomics-Proteomics and Stroke: Introduction Stroke, November 1, 2004; 35(11_suppl_1): 2731 - 2734. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Frikke-Schmidt, B. G. Nordestgaard, P. Schnohr, and A. Tybjaerg-Hansen Single nucleotide polymorphism in the low-density lipoprotein receptor is associated with a threefold risk of stroke: A case-control and prospective study Eur. Heart J., June 1, 2004; 25(11): 943 - 951. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z Szolnoki, F Somogyvari, A Kondacs, M Szabo, L Fodor, J Bene, and B Melegh Evaluation of the modifying effects of unfavourable genotypes on classical clinical risk factors for ischaemic stroke J. Neurol. Neurosurg. Psychiatry, December 1, 2003; 74(12): 1615 - 1620. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.C. Kofoed, H.H. Wittrup, H. Sillesen, and B.G. Nordestgaard Fibrinogen predicts ischaemic stroke and advanced atherosclerosis but not echolucent, rupture-prone carotid plaques: The Copenhagen City Heart Study Eur. Heart J., March 2, 2003; 24(6): 567 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Dahl, A. Tybjaerg-Hansen, H. Sillesen, G. Jensen, R. Steffensen, and B. G. Nordestgaard Blood Pressure, Risk of Ischemic Cerebrovascular and Ischemic Heart Disease, and Longevity in {alpha}1-Antitrypsin Deficiency: The Copenhagen City Heart Study Circulation, February 11, 2003; 107(5): 747 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Rahmutula, T. Nakayama, Y. Izumi, Y. Ozawa, H. Shimabukuro, H. Kawamura, S. Zhen-Wang, J. Xiong-Wang, M. Aisa, C. Run-Yang, et al. Angiotensin-Converting Enzyme Gene and Longevity in the Xin Jiang Uighur Autonomous Region of China: An Association Study J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2002; 57(1): M57 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Niskanen, T. Hedner, L. Hansson, J. Lanke, and A. Niklason Reduced Cardiovascular Morbidity and Mortality in Hypertensive Diabetic Patients on First-Line Therapy With an ACE Inhibitor Compared With a Diuretic/{beta}-Blocker-Based Treatment Regimen: A subanalysis of the Captopril Prevention Project Diabetes Care, December 1, 2001; 24(12): 2091 - 2096. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Sethi, A. Tybjaerg-Hansen, M.-L. M. Gronholdt, R. Steffensen, P. Schnohr, and B. G. Nordestgaard Angiotensinogen Mutations and Risk for Ischemic Heart Disease, Myocardial Infarction, and Ischemic Cerebrovascular Disease: Six Case-Control Studies from the Copenhagen City Heart Study Ann Intern Med, May 15, 2001; 134(10): 941 - 954. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Frikke-Schmidt, B.G. Nordestgaard, D. Thudium, M.-L. Moes Gronholdt, and A. Tybjarg-Hansen APOE genotype predicts AD and other dementia but not ischemic cerebrovascular disease Neurology, January 23, 2001; 56(2): 194 - 200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Crisan and J. Carr Angiotensin I-Converting Enzyme: Genotype and Disease Associations J. Mol. Diagn., August 1, 2000; 2(3): 105 - 115. [Full Text]
|
|
|
|
|
|
H. H. Wittrup, B. G. Nordestgaard, H. Sillesen, P. Schnohr, and A. Tybjarg-Hansen A Common Mutation in Lipoprotein Lipase Confers a 2-Fold Increase in Risk of Ischemic Cerebrovascular Disease in Women but Not in Men Circulation, May 23, 2000; 101(20): 2393 - 2397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Agerholm-Larsen, B. G. Nordestgaard, R. Steffensen, G. Jensen, and A. Tybjarg-Hansen Elevated HDL Cholesterol Is a Risk Factor for Ischemic Heart Disease in White Women When Caused by a Common Mutation in the Cholesteryl Ester Transfer Protein Gene Circulation, April 25, 2000; 101(16): 1907 - 1912. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Agerholm-Larsen, B. G. Nordestgaard, and A. Tybjarg-Hansen ACE Gene Polymorphism in Cardiovascular Disease : Meta-Analyses of Small and Large Studies in Whites Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 484 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. P. Mancini, M. Margaglione, A. Tufano, A. Celentano, L. A. Ferrara, V. Colantuoni, G. Di Minno, A. Tybjærg-Hansen, B. Agerholm-Larsen, and B. G. Nordestgaard A Fast and Accurate Method for Genotyping the Angiotensin-Converting Enzyme I/D Polymorphism • Response Circulation, March 31, 1998; 97(12): 1213 - 1214. [Full Text] [PDF]
|
|
Article
